Screening for retinopathy every 2 years instead of the recommended annual screening would be safe and could reduce screening costs by about 25% for people in the United Kingdom who have type 2 diabetes but who have not developed retinopathy, according to an article published online May 7 in Diabetes Care. Current guidelines by the United Kingdom's National Institute for Health and Clinical Excellence (NICE) recommend either annual retinopathy screenings for people with diabetes or, if the patients have developed retinopathy beyond mild disease, screenings every 3 to 6 months. To see more details visit, www.medscape.com
